Most Active Stocks

Leading the Charge in Embodied AI Hey, here's a wild one: X Square Robot is stepping into the limelight with its Quanta X1 Pro, rightfully snagging itself a spot as a CES Innovation Awards® 2027 Honoree. Now, before you roll your eyes and think "just another gizmo," let me walk you through why this actually matters and the ripples it might send through both tech and...

Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...

Pentixapharm and Eckert & Ziegler's Extended Bond Play Fresh off the Berlin newswire, Pentixapharm Holding AG made a bold move with Eckert & Ziegler SE (EZAG). This isn't your everyday handshake, folks. We're talking about extending a 4.00% convertible bond from 2027 all the way out to 2030. There's a twist: the interest rate's ticking up to 6.00% starting in 2027. So,...

Flo Health Reaches New Milestone with ISO 13485 Hey, it's not every day you see a tech company pull off an ISO 13485 certification. Flo Health, the top dog in the women's health app battleground, has just earned that badge. And let's not sugarcoat it—this isn't your run-of-the-mill certification. It's a heavyweight endorsement of a quality management system (QMS) that...

LAE124 Could Shake Up Obesity Treatment Norms Just roll the dice on innovation sometimes, because that's when you get a spark. Laekna, a name you’ve heard in biotech circles, is gearing up to showcase LAE124 at Obesity Week 2026. This ain't just another weight-loss compound tossed into the market. We're talking about a new small-molecule dual Amylin/Calcitonin receptor...

Allegiant and Bank of America: A Decade of Partnership Picture Allegiant Travel Company (NASDAQ: ALGT) and Bank of America (NYSE: BAC) shaking hands over a table that's seen ten years of successful collaboration. They're not just renewing vows; they're doubling down, announcing a long-term extension of their co-branded credit card partnership. In a world where loyalty...

Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...

Class Action Shadows AppLovin Over AI Promises What a tangled web AppLovin has woven for itself. Promises of rapid AI advancements and a slick video tool rollout seemed like a done deal back in the early months of 2026. Well, that was until the cracks started to show by August. Promises Made, Promises Broken The saga kicked off on May 6, 2026, with AppLovin's confident...

Honoring Progress in Medication Safety Boy, if there's one thing that's clear in the world of healthcare, it's that nothing's more vital than patient safety. The Institute for Safe Medication Practices (ISMP) is more than a fine-toothed comb in that realm; it's basically the gold standard. Every year, they shine a light on folks and organizations wrestling with the beast...

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Assurant Stock Hits 52-Week Low In the midst of evolving market conditions, Assurant Inc. (NYSE: AIZ) has seen its stock price drop to a notable 52-week low of $19.85. This decline translates to a 1-year change of -2.2%, prompting investors to reassess their strategies. However, amid this downturn, Assurant continues to exhibit robust fundamentals, evidenced by its...

Ona Therapeutics Strengthens Leadership Team for Innovative Cancer Therapies Ona Therapeutics is making waves in the biotech industry with its recent strategic leadership appointments aimed at fast-tracking the development of innovative antibody-drug conjugates (ADCs). These ADCs are designed to target and destroy hard-to-treat cancer cells across various solid tumor...

New Jersey Digital Marketing Conference is Back! Mark your calendars for the much-anticipated return of the New Jersey Digital Marketing Conference (NJDMC) on October 23, 2025, at the historic Bell Works campus. This vibrant event aims to unite innovative marketers, industry leaders, and creative thinkers for an inspiring day filled with learning and networking. A Day of...

Hancock Health Partners with Revology for Enhanced Revenue Operations Hancock Health is excited to announce its partnership with Revology aimed at transforming its revenue cycle management (RCM) operations. This collaboration marks a significant step towards adopting advanced technology that promises to improve efficiency and transparency in the billing processes....

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC, a respected entity in the financial sector, has been gaining attention among investors. This protected cell company, incorporated in Jersey with registration number 93546, operates under the legal entity identifier 2138007ENW3JEJXC8658. Known for its strategic investments, the company focuses on...